Mangoceuticals (MGRX) Competitors $1.47 +0.04 (+2.80%) As of 10:30 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock MGRX vs. CCM, MRAI, ENZ, BRTX, BGLC, SSY, ATIP, ACON, DHAC, and VSEEShould you be buying Mangoceuticals stock or one of its competitors? The main competitors of Mangoceuticals include Concord Medical Services (CCM), Marpai (MRAI), Enzo Biochem (ENZ), Biorestorative Therapies (BRTX), BioNexus Gene Lab (BGLC), SunLink Health Systems (SSY), ATI Physical Therapy (ATIP), Aclarion (ACON), Digital Health Acquisition (DHAC), and VSee Health (VSEE). These companies are all part of the "healthcare" industry. Mangoceuticals vs. Its Competitors Concord Medical Services Marpai Enzo Biochem Biorestorative Therapies BioNexus Gene Lab SunLink Health Systems ATI Physical Therapy Aclarion Digital Health Acquisition VSee Health Mangoceuticals (NASDAQ:MGRX) and Concord Medical Services (NYSE:CCM) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their valuation, profitability, risk, media sentiment, analyst recommendations, dividends, earnings and institutional ownership. Do insiders and institutionals believe in MGRX or CCM? 56.7% of Mangoceuticals shares are owned by institutional investors. 16.0% of Mangoceuticals shares are owned by insiders. Comparatively, 46.5% of Concord Medical Services shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Does the media favor MGRX or CCM? In the previous week, Concord Medical Services had 3 more articles in the media than Mangoceuticals. MarketBeat recorded 4 mentions for Concord Medical Services and 1 mentions for Mangoceuticals. Mangoceuticals' average media sentiment score of 1.87 beat Concord Medical Services' score of 0.00 indicating that Mangoceuticals is being referred to more favorably in the media. Company Overall Sentiment Mangoceuticals Very Positive Concord Medical Services Neutral Which has stronger earnings & valuation, MGRX or CCM? Mangoceuticals has higher earnings, but lower revenue than Concord Medical Services. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMangoceuticals$511.08K14.87-$8.71M-$4.64-0.32Concord Medical Services$52.60M0.49-$42.23MN/AN/A Is MGRX or CCM more profitable? Concord Medical Services has a net margin of 0.00% compared to Mangoceuticals' net margin of -2,191.76%. Concord Medical Services' return on equity of 0.00% beat Mangoceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Mangoceuticals-2,191.76% -72.81% -66.58% Concord Medical Services N/A N/A N/A Which has more risk and volatility, MGRX or CCM? Mangoceuticals has a beta of 2.4, suggesting that its stock price is 140% more volatile than the S&P 500. Comparatively, Concord Medical Services has a beta of -0.9, suggesting that its stock price is 190% less volatile than the S&P 500. SummaryConcord Medical Services beats Mangoceuticals on 6 of the 11 factors compared between the two stocks. Get Mangoceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for MGRX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MGRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MGRX vs. The Competition Export to ExcelMetricMangoceuticalsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$7.60M$2.45B$5.52B$9.35BDividend YieldN/A1.79%4.25%4.09%P/E Ratio-0.329.2227.9519.83Price / Sales14.87761.91438.79106.18Price / CashN/A160.6835.5357.53Price / Book0.344.718.255.72Net Income-$8.71M$30.99M$3.23B$257.51M7 Day Performance-10.91%0.47%-0.13%0.59%1 Month Performance-24.23%9.59%7.21%10.74%1 Year Performance-98.46%-3.76%27.45%15.87% Mangoceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MGRXMangoceuticals0.9826 of 5 stars$1.47+2.8%N/A-98.5%$7.60M$511.08K-0.323CCMConcord Medical Services0.7711 of 5 stars$5.79+3.0%N/A-35.4%$25.13M$52.60M0.00970News CoverageMRAIMarpaiN/A$1.22-3.9%N/A+103.8%$20.17M$34.87M-0.46150ENZEnzo BiochemN/A$0.33-14.8%N/A-71.7%$17.03M$29.09M0.00520Gap DownHigh Trading VolumeBRTXBiorestorative Therapies3.5803 of 5 stars$1.72+13.2%$18.00+946.5%-9.1%$12.90M$400K-1.177News CoverageBGLCBioNexus Gene Lab1.2691 of 5 stars$6.39+7.8%N/A-18.3%$11.50M$9.51M0.0030Gap UpSSYSunLink Health Systems2.1451 of 5 stars$1.00-2.0%N/A+19.0%$7.04M$31.09M7.141,376ATIPATI Physical TherapyN/A$1.03+4.0%N/A-83.2%$4.54M$741.86M-0.065,600Gap UpACONAclarion2.8227 of 5 stars$7.61-1.8%$11,758.50+154,413.8%-99.7%$4.43M$54.60K0.007DHACDigital Health AcquisitionN/A$1.17-1.7%N/A-78.7%$4.22MN/A0.002,021VSEEVSee Health0.8717 of 5 stars$1.15flat$5.00+334.8%-79.2%$4.14MN/A0.00N/A Related Companies and Tools Related Companies CCM Alternatives MRAI Alternatives ENZ Alternatives BRTX Alternatives BGLC Alternatives SSY Alternatives ATIP Alternatives ACON Alternatives DHAC Alternatives VSEE Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MGRX) was last updated on 7/17/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredThe DOJ Just Paved the Way for Account SeizuresWashington is running out of money…And guess where they'll look next? When governments go broke, they take ...Priority Gold | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mangoceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mangoceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MGRX Stock Alerts